219111- A retrospective matched cohort database study in the United States to evaluate the effectiveness of recombinant zoster vaccine (RZV) in patients with autoimmune diseases (AIDs) (EPI-ZOSTER-097 VE US DB)

13/10/2022
13/12/2024
EU PAS number:
EUPAS49294
Study
Finalised
Documents
Study protocol
Initial protocol
English (1.26 MB - PDF) View document
Study results
Study report
Study report
English (4.02 MB - PDF) View document
Other information